The transgenic rat models of tauopathy replicated crucial features of Alzheimer’s disease, such as tau hyperphosphorylation, insoluble tau formation, neurofibrillary pathology, and reduction in life span (Zilka et al., 2006; Koson et al., 2008). The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.